Health economics: Second edition

Health Economics: Second Edition

Volumn , Issue , 2009, Pages 1-529

  Zweifel, Peter ^a   Kifmann, Mathias ^b   Breyer, Friedrich ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF AUGSBURG   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892324625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-68540-1     Document Type: Book

References (475)

1. Allais, M. (1953). Le Comportement de l'Homme Rationelle devant le Risque. Critique de Postulats et Axiomes de l'́ecole Améericaine, Econometrica 21: 503-546
2. Allen, R. AND Gertler, P. (1991). Regulation and the Provision of Quality to Heterogenous Consumers: The Case of Prospective Pricing of Medical Services, Journal of Regulatory Economics 3: 361-375
3. Arrow, K. (1951). Alternative Approaches to the Theory of Choice in Risk-Taking Situations, Econometrica 19: 404-437
4. Arrow, K. (1962). Economic Welfare and the Allocation of Resources for Invention, in K. ARROW(ed.), The Rate and Direction of Inventive Activity, Princeton University Press, Princeton, NJ, 609-625
5. Arrow, K. (1963). Uncertainty and the Welfare Economics of Medical Care, American Economic Review 53: 941-973
6. Arrow, K. (1970). Essays in the Theory of Risk-Bearing, North Holland, Amsterdam
7. Arrow, K. (1974). Optimal Insurance and Generalized Deductibles, Scandinavian Actuarial Journal 57: 1-42
8. Ash, A., ellis, R. AND YU.W. (1998). Risk Adjusted PaymentModels for the Non-Elderly, Final report, Health Care Financing Administration, Washington, DC.
9. Atkinson, A., Rainwater, L. AND Smeeding, T. (1995). Income Distribution in OECD Countries, OECD, Paris
10. Auster, R., Leveson, I. AND Sarachek, D. (1969). The Production of Health, an Exploratory Study, Journal of Human Resources 4: 411-436
11. Averch, H. AND Johnson, L. (1962). Behavior of the Firm Under Regulatory Constraint, American Economic Review 52: 1053-1069
12. Baily, M. (1972). Research and Development Costs and Returns: The U.S. Pharmaceutical Industry, Journal of Political Economy 80: 78-85
13. Banker, R. D., Charnes, A. AND Cooper, W. (1984). Some Models for Estimating Technical and Scale Inefficiencies in Data Envelopment Analysis, Management Science 30: 1078-92
14. Barr, N. (2004). The Economics of the Welfare State, 4th edition, Oxford University Press, Oxford
15. Baumol, W. AND Bradford, D. (1970). Optimal Departures FromMarginal Cost Pricing, American Economic Review 60: 265-283
16. Baumol, W., Panzar, J. AND Willig, R. (1982). Contestable Markets and the Theory of Industrial Structure, Harcourt Brace Jovanovich, New York
17. P. Zweifel et al., Health Economics, 2nd ed., DOI 10.1007/978-3-540- 68540-1BM2, © Springer-Verlag Berlin Heidelberg 2009
18. Beck, K. AND Zweifel, P. (1998). Cream-Skimming in Deregulated Social Health Insurance: Evidence from Switzerland, in P. ZWEIFEL (ed.), Health, the Medical Profession and Regulation, Kluwer, Dordrecht, 211-227
19. Becker, G. (1965). A Theory of the Allocation of Time, Economic Journal 75: 493-517
20. Behrend, C., Gress, S., Holle, R., Reitmeir, P., Tolksdorff, K. AND Wasem, J. (2004). Zur Erklárungskraft des heutigen soziodemografischen Risikostrukturausgleichsmodells - Ergebnisse empirischer Analysen an Prozessdaten einer ostdeutschen Regionalkasse, Journal of Public Health - Zeitschrift für Gesundheitswissenschaften 12: 20- 31
21. Benham, L. (1991). Licensure and Competition in Medical Markets, in H. FRECH, III (ed.), Regulating Doctors' Fees: Competition, Benefits and Controls under Medicare, AEI Press, Washington, DC, 75-90
22. Bennett, J. AND Blamey, R. (2001). The Choice Modelling Approach to Environmental Valuation, Edward Elgar, Cheltenham UK, Northampton MA.
23. Beraldo, S., Montolio, D. AND Turati, G. (2007). Healthy, Educated and Wealthy: Is the Welfare State Really Harmful for Growth, Department d'Hisenda Publica. Universitat de Barcelona .
24. Bhattacharyya, G. AND Johnson, R. (1977). Statistical Concepts and methods, J.Wiley & Sons, New York
25. Birch, S. AND Gafni, A. (1992). Cost Effectiveness/Utility Analyses: Do Current Decision Rules Lead Us Where We Want to Be?, Journal of Health Economics 11: 279-296
26. Birch, S. AND Gafni, A. (2006a). Decision Rules in Economic Evaluation, in A. JONES (ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, 492-502
27. Birch, S. AND Gafni, A. (2006b). Information Created to Evade Reality (ICER), PharmacoEconomics 24: 1121-1131
28. Blackorby, C. AND Donaldson, D. (1990). The Case Against the Use of the Sum of Compensating Variations in Cost-Benefit Analysis, Canadian Journal of Economics 23: 471-494
29. Blamey, R., Bennett, J. AND Morrison, M. (1999). Yea-Saying in Contingent Valuation Survey, Land Economics 75: 126-141
30. Bleichrodt, H. (2002). A New Explanation for the Difference Between Time-Tradeoff Utilities and Standard Gamble Utilities, Health Economics 11: 447-456
31. Bleichrodt, H. AND Johannesson, M. (1997). An Experimental Test of the Theoretical Foundation of Rating-Scale Valuations, Medical Decision Making 17: 208-216
32. Bleichrodt, H. AND Pinto, J. (2005). The Volatility of QALYs Under Non-Expected Utility, Economic Journal 115: 533-550
33. Bleichrodt, H. AND Quiggin, J. (1997). Characterizing QALYs Under a General Rank Dependent Utility Model, Journal of Risk and Uncertainty 15: 151-165
34. Bleichrodt, H. AND Quiggin, J. (1999). Life-Cycle Preferences Over Consumption and Health:When Is Cost-Effectiveness Analysis Equivalent to Cost-Benefit Analysis?, Journal of Health Economics 18: 681-708
35. Bleichrodt, H., Wakker, P. AND Johannesson, M. (1997). Characterizing QALYs by Risk Neutrality, Journal of Risk and Uncertainty 15: 107-114
36. Blomquist, S. AND Christiansen, V. (1999). The Political Economy of Publicly Provided Private Goods, Journal of Public Economics 73: 31-54
37. BLOMQVIST, A. (1997). Optimal Non-Linear Health Insurance, Journal of Health Economics 16: 303-321
38. Boadway, R. AND Bruce, N. (1984). Welfare Economics, Basil Blackwell, Oxford
39. Boadway, R., LEITE-MONTEIRO.M., Marchand, M. AND Pestieau, P. (2003). Social Insurance and Redistribution, in S. CNOSSEN AND H-W. SINN (eds.), Public Finance and Public Policy in the New Millenium, McMillan
40. Borck, R. (2007). Voting, Inequality, and Redistribution, Journal of Economic Surveys 21: 90-109
41. Brenner, H. (1979). Mortality and the National Economy: A Review and the Experience of England and Wales, 1936-76, Lancet 314: 568-573
42. Brenner, H. (1983). Mortality and Economic Instability: Detailed Analyses for Britain, in J. JOHN (ed.), Influence of Economic Instability on Health, Springer, Berlin, 28-84
43. Breuer, M. (2006). Optimal Insurance Contracts without the Non-Negativity Constraint on Indemnities, Revisited, Geneva Risk and Insurance Review 31: 5-9
44. Breyer, F. (1991). Distribution Effects of Coinsurance Options in Social Health Insurance Systems, in G. L'O PEZ-CASASNOVAS (ed.), Incentives in Health Systems, Springer, Berlin, 120-133
45. Breyer, F. (1995). The Political Economy of Rationing in Social Health Insurance, Journal of Population Economics 8: 137-148
46. Breyer, F. AND Felder, S. (2005). Mortality Risk and the Value of a Statistical Life: The Dead-Anyway Effect Revis(it)ed, Geneva Risk and Insurance Review 30: 14-55
47. Breyer, F. AND Felder, S. (2006). Life Expectancy and Health Care Expenditures in the 21st Century: A New Forecast for Germany Using the Costs of Dying, Health Policy 75: 178-186
48. Breyer, F., Heineck, M. AND Lorenz, N. (2003). Determinants of Health Care Utilization by German Sickness Fund Members - With Application to Risk Adjustment, Health Economics 12: 367-376
49. Breyer, F., Kliemt, H. AND Thiele, F. (eds.) (2001). Rationing in Medicine: Ethical, Legal and Practical Aspects, Springer, Berlin
50. Breyer, F. AND Schultheiss, C. (2002). "Primary" Rationing of Health Services in Ageing Societies - A Normative Analysis, International Journal of Health Care Finance and Economics 2: 247-264
51. Brook, R., WARE, JR., J., Rogers, W., Keeler, E., Davies, A., Donald, C., Goldberg, G., Lohr, K., Masthay, P. AND Newhouse, J. (1983). Does Free Care Improve Adults' Health? Results froma Randomized Controlled Trial, New England Journal of Medicine 309: 1426-1434
52. Broome, J. (1982a). Trying to Value a Life, Journal of Public Economics 9: 91-100
53. Broome, J. (1982b). Uncertainty inWelfare Economics and the Value of Life, in M. JONESLEE (ed.), The Value of Life and Safety, North Holland, Amsterdam, 201-216
54. Bryan, S., Buxton, M., Sheldon, R. AND Grant, A. (1998). Magnetic Resonance Imaging for the Investigation of Knee Injuries: An Investigation of Preferences, Health Economics 7: 595-603
55. Bryan, S., Gold, L., Sheldon, R. AND Buxton, M. (2000). Preference Measurement Using Conjoint Methods: An Empirical Investigation of Reliability, Health Economics 9: 385-395
56. BUNDESAMT Fü R STATISTIK (1973). Statistisches Jahrbuch der Schweiz, Verlag Neue Zurcher Zeitung, Zürich
57. BUNDESMINISTERIUM FUR GESUNDHEIT (2001). Daten des Gesundheitswesens, Schriftenreihe des Bundesministeriums für Gesundheit, Vol. 137, Stuttgart
58. Butler, J. (1999). The Ethics of Health Care Rationing, Cassell, London et al.
59. Byrne, M., O'malley, K. AND SUAREZ-Almazor, M. (2005). Willingness to Pay Per Quality-Adjusted Life Year in a Study of Knee Osteoarthritis, Medical Decision Making 25: 655-666
60. Cameron, A., Trivedi, P., Milne, F. AND Piggott, J. (1988). A Microeconometric Model of the Demand for Health Care and Health Insurance in Australia, Review of Economic Studies 55: 85-106
61. Carlsen, F. AND Grytten, J. (1998). More Physicians: Improved Availability or Induced Demand?, Health Economics 7: 495-508
62. Carlton, D. AND Perloff, J. (2000). Modern Industrial Organization, 3rd edition, Addison-Wesley, Reading MA.
63. Chalkley, M. AND Malcomson, J. (1998a). Contracting for Health Services when Patient Demand Does Not Reflect Quality, Journal of Health Economics 17: 1-19
64. Chalkley, M. AND Malcomson, J. (1998b). Contracting for Health Services with Unmonitored Quality, Economic Journal 108: 1093-1110
65. Chalkley, M. AND Malcomson, J. (2000). Government Purchasing of Health Services, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. Band 1A, Elsevier, Amsterdam, 847-890
66. CHARNES, A., COOPER,W. AND Rhodes, E. (1978). Measuring the Efficiency of Decision Making Units, European Journal of Operational Research 2: 429-444
67. Chollet, D. AND Lewis, M. (1997). Private Insurance: Principles and Practice, in G. J. SCHIEBER (ed.), Innovations in Health Care Financing: Proceedings of a World Bank Conference, Nr. 365 in World Bank Discussion Paper, World Bank, Washington, DC, 77-114
68. Christensen, L., Jorgenson, D. AND LAU, L. (1973). Transcendental Logarithmic Production Frontiers, Review of Economics and Statistics 55: 28-45
69. Clark, D., Korff, M. V., Sanders, K., BALUCH,W. AND Simon, G. (1995). A Chronic Disease Score with Empirically Derived Weights, Medical Care 33: 783-795
70. Coate, S. (1995). Altruism, the Samaritans Dilemma and Government Transfer Policy, American Economic Review 85: 46-57
71. Cochrane, J. (1995). Time-Consistent Health Insurance, Journal of Political Economy 103: 445-473
72. Coelli, T., Rao, D. AND Battese, G. (1998). An Introduction to Efficiency and Productivity Analysis, Kluwer, Dordrecht
73. Comanor, W. (1986). The Political Economy of the Pharmaceutical Industry, Journal of Economic Literature 24: 1178-1217
74. COMANOR,W., FRECH, Iii, H. AND MILLER, JR., R. (2006). Is the United States an Outlier in Health Care and Health Outcomes? A Preliminary Analysis, International Journal of Health Care Finance and Economics 6: 3-23
75. Congleton, R. (2003). The Median Voter Model, in C. ROWLEY AND F. SCHNEIDER (eds.), The Encyclopedia of Public Choice, Kluwer, 382-386
76. CONGRESSIONAL BUDGET OFFICE (1998). How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry, Congressional Budget Office, Washington, DC. http://www.cbo.gov/doc.cfm?index= 655
77. Cook, P. AND Graham, D. (1977). The Demand for Insurance Protection: The Case of Irreplaceable Commodities, Quarterly Journal of Economics 91: 143-156
78. Cooper, W., Seiford, L. AND Tone, K. (2006). Data Envelopment Analysis: A Comprehensive Text with Models, Applications, References and DEA-Solver Software, 2nd edition, Springer, New York
79. Cremer, H. AND Pestieau, P. (1996). Redistributive Taxation and Social Insurance, International Tax and Public Finance 3: 281-295
80. Crocker, K. AND Snow, A. (1985a). The Efficiency of Competitive Equilibria in Insurance Markets with Asymmetric Information, Journal of Public Economics 26: 207-219
81. Crocker, K. AND Snow, A. (1985b). A Simple Tax Structure for Competitive Equilibrium and Redistribution in Insurance Markets with Asymmetric Information, Southern Economic Journal 51: 1142-50
82. Culyer, A. (1971). The Nature of the Commodity Health Care and its Efficient Allocation, Oxford Economic Papers 23: 189-211
83. Culyer, A. (1989). The Normative Economics of Health Care Finance and Provision, Oxford Review of Economic Policy 5: 34-58
84. Culyer, A. (1990). Commodities, Characteristics of Commodities, Characteristics of People, Utilities, and Quality of Life, in S. Baldwin, C. GODFREY AND C. PROPPER (eds.), Quality of Life: Perspectives and Policies, Routledge, London, 9-27
85. Cummings, R., Brookshire, D. AND SCHULZE.W. (1986). Valuing Environment Goods: An Assessment of the Contingent Valuation Method, Littlefield, Totowa, NJ.
86. Cutler, D. AND Reber, S. (1998). Paying for Health Insurance: The Trade-Off Between Competition and Adverse Selection, Quarterly Journal of Economics 113: 433-466
87. Cutler, D. AND Zeckhauser, R. (2000). The Anatomy of Health Insurance, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 563-643
88. Dafny, L. (2005). How Do Hospitals Respond to Price Changes?, American Economic Review 95: 1525-1547
89. Dahlby, B. (1981). Adverse Selection and Pareto Improvements Through Compulsory Insurance, Public Choice 37: 547-558
90. Danzon, P. (1997a). Pharmaceutical Price Regulation - National Policies versus Global Interests, AEI Press, Washington, DC.
91. Danzon, P. (1997b). Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU, International Journal of the Economics of Business 4: 301-321
92. Danzon, P. (2000). Liability for Medical Malpractice, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1339-1404
93. Danzon, P. AND Chao, L-W. (2000). Cross-National Price Differences for Pharmaceuticals: How Large, and Why?, Journal of Health Economics 19: 159-195
94. DARB A, J. AND Rovira, J. (1998). Parallel Imports of Pharmaceuticals in the European Union, PharmacoEconomics 14 (Suppl.1): 129-136
95. Darby, M. AND Karni, E. (1973). Free Competition and the Optimal Amount of Fraud, Journal of Law & Economics 16: 67-88
96. Dasgupta, P. AND Maskin, E. (1986). The Existence of Equilibrium in Discontinuous Economic Games, Review of Economic Studies 46: 1-41
97. Dave, D. AND Kaestner, R. (2006). Health Insurance and Ex Ante Moral Hazard: Evidence from Medicare, NBER Working Paper 12764
98. Deb, P. AND Trivedi, P. (2006). Empirical Models of Health Care Use, in A. JONES (ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, 147-155
99. Debreu, G. (1959). Theory of Value: An Axiomatic Analysis of Economic Equilibrium, Wiley, London
100. Debrock, L. (1985). Market Structure, Innovation and Optimal Patent Life, Journal of Law and Economics 28: 223-44
101. Devarajan, S., Swaroop, V. AND Zou, H-F. (1996). The Composition of Public Expenditure and Economic Growth, Journal of Monetary Economics 37: 313-344
102. Diewert, W. (1974). Applications of Duality Theory, in M. INTRILIGATOR AND D. KENDRICK (eds.), Frontiers of Quantitative Economics, Vol. II, North-Holland, Amsterdam, 106-171
103. Dimasi, J., Hansen, R. AND Grabowski, H. (2003). The Price of Innovation: New Estimates of Drug development Costs, Journal of Health Economics 22: 151-185
104. Dimasi, J., Hansen, R., Grabowski, H. AND Lasagna, L. (1991). Cost of Innovation in the Pharmaceutical Industry, Journal of Health Economics 10: 107-142
105. Dionne, G. (1992). Contributions to Insurance Economics, Kluwer, Dordrecht
106. Dionne, G. (2000). Handbook of Insurance, Kluwer, Dordrecht
107. Dionne, G. AND Doherty, N. (1992). Adverse Selection in Insurance Markets: A Selective Survey, in G. DIONNE (ed.), Contributions to Insurance Economics, Kluwer, Dordrecht, 97-140
108. Dolan, P. (2000). The Measurement of Health-Related Quality of Life for Use in Resource Allocation Decisions in Health Care, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1723-1760
109. Dranove, D. (1987). Rate-Setting by Diagnosis Related Groups and Hospital Specialization, Rand Journal of Economics 18: 417-427
110. Dranove, D. (1988). Pricing by Non-Profit Institutions: Cost Shifting, Journal of Health Economics 7: 47-57
111. Dranove, D. AND Satterthwaite, M. (2000). The Industrial Organization of Health Care Markets, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1093-1139
112. Dranove, D. AND Wehner, P. (1994). Physician-Induced Demand for Childbirths, Journal of Health Economics 13: 61-73
113. Dreze, J. (1962). L'Utilit́e Sociale d'une Vie Humaine, Revue Française de Recherche Oṕerationelle 1: 93-118
114. Drummond, M., Sculpher, M., Torrance, G., O'brien, B. AND Stoddart, G. (2005). Methods for the Economic Evaluation of Health Care Programmes, 3rd edition, Oxford University Press, Oxford
115. Duan, N. (1983). Smearing Estimate: A Nonparametric Retransformation Method, Journal of the American Statistical Association 78: 605-690
116. Duan, N., Manning, W., Morris, C. AND Newhouse, J. (1984). Choosing Between the Sample-SelectionModel and theMulti-PartModel, Journal of Business and Economic Statistics 2: 283-289
117. Eeckhoudt, L., Gollier, C. AND Schlesinger, H. (2005). Economic and Financial Decisions Under Risk, Princeton University Press, Princeton
118. Eisner, R. AND Strotz, R. (1961). Flight Insurance and the Theory of Choice, Journal of Political Economy 69: 355-368
119. Ellis, R. (1998). Creaming, Skimping and Dumping: Provider Competition on the Intensive and Extensive Margins, Journal of Health Economics 17: 537-555
120. Ellis, R. (2008). Risk Adjustment in Health Care Markets: Concepts and Applications, in M. LU AND E. JONSSON (eds.), Financing Health Care: New Ideas for a Changing Society, Wiley-VCH, Weinheim, 177-222
121. Ellis, R. AND Mcguire, T. (1986). Provider Behavior Under Prospective Reimbursement: Cost Sharing and Supply, Journal of Health Economics 5: 129-151
122. Emons, W. (1997). Credence Goods Monopolists, International Journal of Industrial Organization 19: 357-389
123. Enthoven, A. (1980). Health Plan: The Only Practical Solution to the Soaring Cost of Medical Care, Addison-Wesley, Reading, MA.
124. Enthoven, A. (1988). Theory and Practice of Managed Competition in Health Care Finance, North Holland, Amsterdam
125. Epple, D. AND Romano, R. (1996a). Ends Against theMiddle: Determining Public Service Provision when There Are Private Alternatives, Journal of Public Economics 62: 297- 325
126. Epple, D. AND Romano, R. (1996b). Public Provision of Private Goods, Journal of Political Economy 104: 57-84
127. Eugster, P. AND Zweifel, P. (2006). Correlated Risks: A Conflict of Interest Between Insurers and Consumers and Its Resolution, Working paper, University of Zurich
128. Evans, R. (1974). Supplier-Induced Demand: Some Empirical Evidence and Implications, in M. PERLMAN (ed.), The Economics of Health and Medical Care, Macmillan, New York, 162-173
129. Evans, R. (1984). Strained Mercy. The Economics of Canadian Health Care, Butterworths, Toronto
130. Fama, E. (1976). Foundations of Finance, Basil Blackwell, New York
131. Fayissa, B. AND Gutema, P. (2005). Estimating a Health Production Function for Sub-Saharan Africa (SSA), Applied Economics 37: 155-164
132. FEDERAL STATISTICAL OFFICE OF GERMANY (2001). Statistical Yearbook (Statistisches Jahrbuch), Federal Statistical Office of Germany (Statistisches Bundesamt für Deutschland), Wiesbaden
133. FEDERAL STATISTICAL OFFICE OF GERMANY (2003a). International Statistical Yearbook (Statistische Jahrbuch für das Ausland), Federal Statistical Office of Germany (Statistisches Bundesamt für Deutschland), Wiesbaden
134. FEDERAL STATISTICAL OFFICE OF GERMANY (2003b). Statistical Yearbook (Statistisches Jahrbuch), Federal Statistical Office of Germany (Statistisches Bundesamt für Deutschland), Wiesbaden
135. FEDERAL STATISTICAL OFFICE OF GERMANY (2007). Statistical Yearbook (Statistisches Jahrbuch), Federal Statistical Office of Germany (Statistisches Bundesamt für Deutschland), Wiesbaden
136. Feldman, R., Parente, S. AND Christianson, J. (2007). Consumer Directed Health Plans: New Evidence on Spending and Utilization, Inquiry 44: 26-40
137. Feldstein, P. (2005). Health Care Economics, 6th edition, Delmar, Clifton Park, NY.
138. Feldstein, P. (2006). The Politics of Health Legislation: An Economic Perspective, 3rd edition, Health Administration Press, Chicago
139. Fetter, R., Shin, Y., Freeman, J., Averill, R. AND Thompson, J. (1980). Case-Mix Definition by Diagnosis-Related Groups, Medical Care 18 (Suppl.): 1-53
140. Folland, S., Goodman, A. AND Stano, M. (2006). The Economics of Health and Health Care, 5th edition, Prentice-Hall, Upper Saddle River, NJ.
141. Fougere, M. AND Ḿerette, M. (1999). Population Ageing and Economic Growth in Seven OECD Countries, Economic Modelling 16: 411-427
142. Frank, R., Glazer, J. AND Mcguire, T. (2000). Measuring Adverse Selection in Managed Health Care, Journal of Health Economics 19: 829-854
143. Frankel, M. (1979). Hazard, Opportunity and the Valuation of Life, Preliminary report, Department of Economics, University of Illinois, Urbana-Champaign IL.
144. FRECH, Iii, H. AND MILLER, JR., R. (1999). The Productivity of Health Care and Pharmaceuticals: An International Analysis, The AEI Press, Washington, DC.
145. Frick, K. (1998). Consumer Capital Market Constraints and Guaranteed Renewable Insurance, Journal of Risk and Uncertainty 16: 271-278
146. Fries, J. (1980). Aging, Natural Death, and the Compression of Morbidity, New England Journal of Medicine 303: 130-135
147. Fuchs, V. (1968). The Growing Demand for Medical Care, New England Journal of Medicine 179: 190-195
148. Fuchs, V. (1974). Some Economic Aspects of Mortality in Developed Countries, in M. PERLMAN (ed.), The Economics of Health and Medical Care, Macmillan, London, 174-193
149. Fuchs, V. (1978). The Supply of Surgeons and the Demand for Operations, Journal of Human Resources 13 (Suppl.): 35-56
150. Fuchs, V. (1984a). The "Rationing" of Medical Care, New England Journal of Medicine 311: 1572-1573
151. Fuchs, V. (1984b). Though Much Is Taken: Reflections on Aging, Health and Medical Care, Milbank Memorial Fund Quarterly/Health and Society 61: 143-166
152. Fuchs, V. (1986). The Health Economy, Harvard University Press, Cambridge, MA.
153. Garber, A. (2000). Advances in CE Analysis, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 181-221
154. Gegax, D. AND Stanley, L. (1997). Validating Conjoint and Hedonic Preference Measures: Evidence from Valuing Reductions in Risk, Quarterly Journal of Business and Economics 36: 31-54
155. Gerdtham, U-G. AND Jö Nsson, B. (2000). International Comparisons of Health Expenditure, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. Band 1A, Elsevier, Amsterdam, 11-53
156. Gerdtham, U-G., Jönsson, B., Macfarlan, M. AND Oxley, H. (1998). The Determinants of Health Expenditure in the OECD Countries: A Pooled Data Analysis, in P. ZWEIFEL (ed.), Health, the Medical Profession, and Regulation. Developments in Health Economics and Public Policy, Kluwer Academic, Boston, 113-134
157. Gerdtham, U-G. AND Ruhm, C. (2006). Death Rise in Good Economic Times - Evidence from OECD, Economics and Human Biology 4: 298-316
158. Gerdtham, U-G., Søgaard, J., Jönsson, B. AND Andersson, F. (1992). A Pooled Cross-Section Analysis of the Health Care Expenditures of the OECD Countries, in P. ZWEIFEL AND H. FRECH, III (eds.), Health Economics Worldwide, Kluwer Academic, Boston, 287-310
159. Gerfin, M., Spycher, S. AND Leu, R. (1992). The Validity of the MIMIC Health Index - Some Empirical Evidence, in P. ZWEIFEL AND H. FRECH, III (eds.), Health Economics Worldwide, Kluwer, Dordrecht, 109-142
160. Glazer, J. AND Mcguire, T. (2000). Optimal Risk Adjustment in Markets with Adverse Selection: An Application toManaged Care, American Economic Review 90: 1055-1071
161. Glazer, J. AND Mcguire, T. (2002). Setting Health Plan Premiums to Ensure Efficient Quality in Health Care: Minimum Variance Optimal Risk Adjustment, Journal of Public Economics 84: 153-173
162. Glazer, J. AND Mcguire, T. (2006). Optimal Risk Adjustment, in A. JONES (ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, 279-285
163. Glied, S. (2000). Managed Care, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 707-753
164. Glomm, G. AND Ravikumar, B. (1998). Opting Out of Publicly Provided Services: A Majority Voting Result, Social Choice and Welfare 15: 187-199
165. Goldberger, A. (1974). Unobservable Variables in Econometrics, in P. ZAREMBKA (ed.), Frontiers in Econometrics, Academic Press, New York, 193-213
166. Gollier, C. (1987). The Design of Optimal Insurance Contracts without the Nonnegativity Constraint on Claims, Journal of Risk and Insurance 54: 314-324
167. Gollier, C. (2000). Optimal Insurance Design:What CanWe Do with and without Expected Utility?, in G. DIONNE (ed.), Handbook of Insurance, Kluwer, Dordrecht, 97-116
168. Gottschalk, P. AND Smeeding, T. (1997). Cross-National Comparisons of Earnings and Income Inequality, Journal of Economic Literature 35: 633-687
169. Gould, J. (1969). The Expected Utility Hypothesis and the Selection of Optimal Deductibles for a Given Insurance Policy, Journal of Business 42: 143-151
170. Gouveia, M. (1997). Majority Rule and the Public Provision of a Private Good, Public Choice 93: 221-244
171. Grabowski, H., Hansen, R. AND Dimasi, J. (2002). Returns on Research and Development for 1990s New Drug Introductions, PharmacoEconomics 20 (Suppl.3): 11-29
172. Grabowski, H. AND Vernon, J. (1990). A New Look at the Returns and Risks to Pharmaceutical R&D, Management Science 36: 804-821
173. Grabowski, H. AND Vernon, J. (1994). Returns to R&D on New Drug Introductions in the 1980s, Journal of Health Economics 13: 383-406
174. Grabowski, H. AND Vernon, J. (2000). The Determinants of Pharmaceutical Research and Development Expenditures, Journal of Evolutionary Economics 10: 201-215
175. Gravelle, H. (1984). Editorial: Time Series Analysis of Mortality and Unemployment, Journal of Health Economics 3: 297-306
176. Gravelle, H. AND Rees, R. (2004). Microeconomics, 3rd edition, Pearson Education, Harlow, England
177. Gray, A. AND Phillips, V. (1993). Nursing in a European Labour Market: An Economic Perspective, in C. NORMAN AND J. VAUGHAN (eds.), Europe Without Frontiers. The Implications for health, J. Wiley & Sons, Chichester, 91-110
178. Greene, W. (2008). Econometric Analysis, 6th edition, Prentice Hall, Upper Saddle River, NJ.
179. Greenwald, L., Esposito, A., Ingber, M. AND Levy, J. (1998). Risk Adjustment for the Medicare Program: Lessons Learned from Research and Demonstrations, Inquiry 35: 193-209
180. Grossman, M. (1972a). The Demand for Health: A Theoretical and Empirical Investigation, Columbia University Press of the National Bureau of Economic Research, New York
181. Grossman, M. (1972b). On the Concept of Health Capital and the Demand for Health, Journal of Political Economy 80: 223-250
182. Grossman, M. (2000). The Human Capital Model, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 347-408
183. Gruber, J. AND Owings, M. (1996). Physician Financial Incentives and Cesarean Section Delivery, Rand Journal of Economics 27: 99-123
184. Hadley, J. (ed.) (1982). More Medical Care, Better Health?, Urban Institute, Washington, DC.
185. Hadley, J. AND Zuckermann, S. (1994). The Role of EfficiencyMeasurement in Hospital Rate Setting, Journal of Health Economics 13: 335-340
186. Hailbronner, K. (2005). Union Citizenship and Access to Social Benefits, Common Market Law Review 42: 1245-1267
187. Hammitt, J. AND Graham, J. (1999). Willingness to Pay for Health Protection: Inadequate Sensitivity to Probability?, Journal of Risk and Uncertainty 18: 33-62
188. Hammitt, J. AND Treich, N. (2007). Statistical vs. Identified Lives in Benefit-Cost Analysis, Journal of Risk and Uncertainty 35: 45-66
189. Hansen, R. (1979). The Pharmaceutical Development Process: Estimate of Current Development Cost and Times and the Effects of Regulatory Changes, in R. CHIEN (ed.), Issues in Pharmaceutical Economics, Lexington Books, Lexington MA, 151-187
190. Harsanyi, J. (1955). Cardinal Welfare, Individualistic Ethics, and Interpersonal Comparisons of Utility, Journal of Political Economy 63: 309-321
191. Hausman, J. (1978). Specification Tests in Econometrics, Econometrica 52: 1219-1240
192. HEALTH CARE FINANCING ADMINISTRATION (1983). The New IDC-9-CM Diagnosis- Related Groups Classification Scheme, Johns Hopkins University Press, Baltimore
193. Hellwig, M. (1987). Some Recent Developments in the Theory of Competition in Markets with Adverse Selection, European Economic Review 31: 319-325
194. Hensher, D. (1997). Stated Preference Analysis of Travel Choices: The State of Practice, in T. oum, J. DODGSON AND D. HENSHER (eds.), Transport Economics: Selected Readings, Harwood Academic in cooperation with the Korea Research Foundation for the 21st Century, Amsterdam, 81-109
195. Hoffmeyer, U. AND Mccarthy, T. (1994). Financing Health Care, Vol. I, Kluwer, Dordrecht
196. Hollingsworth, B. (2003). Non-Parametric and Parametric Applications Measuring Efficiency in Health Care, Health Care Management Science 6: 203-218
197. Holmström, B. (1979). Moral Hazard and Observability, Bell Journal of Economics 10(1): 74-91
198. HOLMSTROM, B. AND milgrom, P. (1991). Multitask Principal-Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design, Journal of Law, Economics and Organisation 7: 24-52
199. HOpflinger, F. (1997). Haushalts- und Familienstrukturen im intereuropáischen Vergleich (Structure of Households and Families Across Europe), in S. HRADIL AND S. IMMERFALL (eds.), Die westeuropáischen Gesellschaften im Vergleich, Leske und Budrich, Opladen
200. HOSPITAL CORPORATION OF AMERICA (2009). HCA Fact Sheet, http://www.hcahealthcare.com/CPM/CurrentFactSheet1.pdf
201. Houston, M. (1989). New Insights and New Approaches for the Treatment of Essential Hypertension: Selection of Therapy Based on Coronary Heart Disease Risk Factor Analysis, Hemodynamic Profiles, Quality of Life, and Subsets of Hypertension, American Heart Journal 117: 911-951
202. HOY, M., livernois, J., mckenna, C., rees, R. AND stengos, T. (2001). Mathematics for Economics, 2nd edition, MIT Press, Cambridge, MA.
203. HSIAO,W. (1995). Peer Review:Medical Savings Accounts: Lessons FromSingapore, Health Affairs 14 (2): 260-266
204. Huberman, G., Mayers, D. AND SMITH, JR., C. W. (1983). Optimal Insurance Policy Indemnity Schedules, Bell Journal of Economics 14: 415-426
205. Hurley, J. (2000). An Overview of the Normative Economics of the Health Sector, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 55-118
206. Jack, W. (2006). Optimal Risk Adjustment with Adverse Selection and Spatial Competition, Journal of Health Economics 25: 908-926
207. Jacob, J. AND Lundin, D. (2005). AMedian Voter Model of Health Insurance with Ex Post Moral Hazard, Journal of Health Economics 24: 407-426
208. Jaynes, G. (1978). Equilibria in Monopolistically Competitive Insurance Markets, Journal of Economic Theory 19: 394-422
209. Joglekar, P. AND Paterson, M. (1986). A Closer Look at the Returns and Risks of Pharmaceutical R&D, Journal of Health Economics 5: 107-193
210. Johannesson, M. (1996). Theory and Methods of Economic Evaluation of Health Care, Kluwer, Dordrecht
211. Johannesson, M., Pliskin, J. AND Weinstein, M. (1994). A Note on QALYs, Time Tradeoff, and Discounting, Medical Decision Making 14: 188-193
212. Johansson, P. AND Palme, M. (2005). Moral Hazard and Sickness Insurance, Journal of Public Economics 89: 1879-1890
213. Johnson, F. R., Manzhaf, M. AND Desvousges, W. (2000). Willingness to Pay for Improved Respiratory and Cardiovascular Health: A Multiple-Format, Stated-Preference Approach, Health Economics 9: 295-317
214. Jones, A. (2000). Health Econometrics, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 265-344
215. JONES-Lee, M. (1974). The Value of Changes in the Probability of Death or Injury, Journal of Political Economy 80: 623-648
216. JONES-LEE, M., Hammerton, M. AND Phillips, P. (1985). The Value of Safety: Results of a National Sample Survey, Economic Journal 95: 49-72
217. JOreskog, K. (1973). A General Method for Estimating a Linear Structural Equation System, in A. GOLDBERGER AND O. DUNCAN (eds.), Structural Equation Models in the Social Sciences, Seminar Press, New York, 85-112
218. Kahneman, D. AND Tversky, A. (1979). Prospect Theory: An Analysis of Decision Under Risk, Econometrica 47: 263-291
219. Kannel, W. AND Thom, T. (1984). Declining Cardiovascular Mortality, Circulation 70: 331-336
220. Keeler, E. (1987). The Demand for Episodes of Treatment, Rand
221. Keeler, E. AND Rolph, J. (1983). How Cost Sharing Reduced Medical Spending of Participants in the Health Insurance Experiment, Journal of the American Medical Association 249: 2220-2222
222. Keeney, R. AND Raiffa, H. (1976). Decisions with Multiple Objectives: Preferences and Tradeoffs, Wiley, New York
223. Kessel, R. (1958). Price Discrimination in Medicine, Journal of Law and Economics 1: 20-53
224. Kifmann, M. (1999). Community Rating and Choice Between Traditional Health Insurance and Managed Care, Health Economics 8: 563-578
225. Kifmann, M. (2002). Community Rating in Health Insurance and Different Benefit Packages, Journal of Health Economics 21: 719 - 737
226. Kifmann, M. (2006a). Health Insurance in a Democracy: Why Is It Public and Why Are Premiums Income-Related?, Public Choice 124: 283-308
227. Kifmann, M. (2006b). Risk Selection and Complementary Health Insurance: The Swiss Approach, International Journal of Health Care Finance and Economics 6: 151-170
228. Kifmann, M. AND Lorenz, N. (2009). Optimal Cost Reimbursement of Health Insurers to Reduce Risk Selection, Working paper, Universitát Konstanz
229. King, J., Tsevat, J., Lave, J. AND Roberts, M. (2005). Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation, Medical Decision Making 25: 667-677
230. Klarman, H., Francis, J. AND Rosenthal, G. (1968). Cost-Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease, Medical Care 6: 48-54
231. Klose, T. (1999). The Contingent Valuation Method in Health Care, Health Policy 47: 97-123
232. KRá Mer, W. (1982). Wer leben will, muß zahlen. Die Kostenexplosion im Gesundheitswesen und ihre möglichen Auswirkungen (Who Wants to Live Must Pay. The Cost Explosion in the Health Care Sector and Its Possible Consquences), Econ, Düsseldorf
233. Kumbhakar, S. AND Lovell, C. (2000). Stochastic Frontier Analysis, Cambridge University Press, Cambridge
234. Labelle, R., Stoddart, G. AND Rice, T. (1994). A Re-Examination of the Meaning and Importance of Supplier-Induced Demand, Journal of Health Economics 13: 347-368
235. Laffont, J-J. (1989). The Economics of Uncertainty and Information, MIT Press, Cambridge, MA.
236. Laffont, J-J. AND Tirole, J. (1993). A Theory of Incentives in Procurement and Regulation, MIT Press, Cambridge, MA.
237. Lamers, L. (1999). Risk Adjusted Capitation Based on the Diagnostic Group Model: An Empirical Evaluation with Health Survey in Formation, Health Services Research 33: 1727-1744
238. Lancaster, K. (1966). A New Approach to Consumer Theory, Journal of Political Economy 74: 132-57
239. Lancaster, K. (1971). Consumer Demand: A New Approach, Columbia University Press, New York
240. Lauterbach, K. AND Wille, E. (2000). Modell eines fairen Wettbewerbs durch den Risikostrukturausgleich. Gutachten im Auftrag des Verbandes der Angestellten-Krankenkassen e.V., des AEV-Arbeiter-Ersatzkassen-Verbandes e.V., dem AOKBundesverband und dem IKK-Bundesverband
241. Lave, L. AND Seskin, E. (1977). Air Pollution and Human Health, Johns Hopkins University Press, Baltimore
242. L'E Ger, P. (2008). Physician Payment Mechanisms, in M. LU AND E. JONSSON (eds.), Financing Health Care: New Ideas for a Changing Society,Wiley-VCH, Weinheim, 149-176
243. Lehmann, H. AND Zweifel, P. (2004). Innovation and Risk Selection in Deregulated Social Health Insurance, Journal of Health Economics 23: 997-1012
244. Leu, R. AND Doppmann, R. (1986a). Die Nachfrage nach Gesundheit und Gesundheitsleistungen(Demand for Health and Health Care Services), in G. GáFGEN (ed.), ökonomie des Gesundheitswesens, Duncker & Humblot, Berlin, 161-175
245. LEU, R. AND Doppmann, R. (1986b). Gesundheitszustand und Nachfrage nach Gesundheitsleistungen, in E. WILLE (ed.), Informations- und Planungsprobleme in öffentlichen aufgabenbereichen, P. Lang, Bern, 1-90
246. Leu, R. AND Gerfin, M. (1992). Die Nachfrage nach Gesundheit - Ein empirischer Test des Grossman-Modells, in P. OBERENDER (ed.), Steuerungsprobleme im Gesundheitswesen, Nomos, Baden-Baden, 61-78
247. Levinthal, D. (1988). A Survey of Agency Models of Organizations, Journal of Economic Behavior and Organization 9: 153-185
248. Lichtblau, K. (1999). Internationaler Vergleich der Umsatzrenditen in der Gewerblichen Wirtschaft (International Comparison of Rates of Return on Turnover), IW-Trends 26 (4): 28-38
249. Lichtenberg, F. (2005). The Impact of New Drug Launches on Longevity: Evidence from Longitudinal Disease-Level Data from 52 Countries, 1982-2001, International Journal of Health Care Finance and Economics 5: 47-73
250. Lopez, E., Phillips, L. AND Silos, M. (1992). Deaths from Gastro-Intestinal Cancer in Mexico: Probable Cause for Water Sampling, in P. ZWEIFEL AND H. FRECH, III (eds.), Health Economics Worldwide, Kluwer, Dordrecht, 331-347
251. Louviere, J., Hensher, D. AND Swait, J. (2000). Stated Choice Methods - Analysis and Application, Cambridge University Press, Cambridge
252. Lubitz, J. AND Riley, G. (1993). Trends in Medicare Payments in the Last Year of Life, New England Journal of Medicine 328: 1092-1096
253. Luce, R. D. AND Tukey, J. (1964). Simultaneous Conjoint Measurement - A New Type of Fundamental Measurement, Journal of Mathematical Psychology 1: 1-27
254. Luft, H. (1981). Health Maintenance organizations, J. Wiley, New York
255. LYTTKENS, C. (1999). Imperatives in Health Care. Implications for SocialWelfare and Medical Technology, Nordic Journal of Political Economy 25: 95-114
256. ma, C-T. A. (1994). Health Care Payment Systems: Cost and Quality Incentives, Journal of Economics and Management Strategy 3: 93-112
257. Magnus, J. (1979). Substitution Between Energy and Non-Energy Inputs in the Netherlands 1950-1976, International Economic Review 20: 465-483
258. Malthus, T. (1798). An Essay on the Principle of Population. Reprint by Random House, New York (1960
259. Manning, W. (1998). The Logged Dependent Variable, Heteroskedasticity, and the Retransformation Problem, Journal of Health Economics 17: 283-295
260. MANNING,W., LEIBOWITZ,A., Goldberg, G., ROGERS,W. AND Newhouse, J. (1984). A Controlled Trial on the Effect of a Prepaid Group Practice on Use of Services, New England Journal of Medicine 310: 1505-1510
261. MANNING, W., NEWHOUSE, J., DUAN, N., KEELER, E., Leibowitz, A. AND marquis, M. (1987). Health Insurance and the Demand for Medical Care: Evidence from a Randomized Experiment, American Economic Review 77: 251-277
262. Marchand, M., Sato, M. AND Schokkaert, E. (2003). Prior Health Expenditures and Risk Sharing with Insurers Competing on Quality, RAND Journal of Economics 34: 647-669
263. Markusen, J. (2002). Multinational Firms and the Theory of International Trade, MIT Press, Cambridge, MA.
264. MAS-Colell, A., Whinston, M. AND Green, J. (1995). Microeconomic Theory, Oxford University Press, Oxford
265. Maynard, A. (1991). Developing the Health Care Market, Economic Journal 101: 1277-1286
266. MCCLELLAN,M. (1997). Hospital Reimbursement Incentives: An Empirical Analysis, Journal of Economics and Management Strategy 6: 91-128
267. Mcfadden, D. (1974). Conditional Logit Analysis of Qualitative Choice Behavior, in P. ZAREMBKA (ed.), Frontiers in Econometrics, Academic Press, New York, 105-142
268. Mcguire, A., Henderson, J. AND Mooney, G. (1988). The Economics of Health Care: An Introductory text, J. Wiley, London/New York
269. Mcguire, T. (2000). Physician Agency, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 461-536
270. Mcguire, T. AND Pauly, M. (1991). Physician Response to Fee Changes with Multiple Payers, Journal of Health Economics 10: 385-410
271. Mckeown, T. (1976). The Modern Rise of Population, Edward Arnold, London
272. Mckinlay, J., Mckinlay, S. AND Beaglehole, R. (1989). A Review of the Evidence Concerning the Impact of Medical Measures on Recent Mortality and Morbidity in the United States, International Journal of Health Services 19: 181-208
273. Mehrez, A. AND Gafni, A. (1989). Quality-Adjusted Life Years, Utility Theory, and Healthy-Years-Equivalents, Medical Decision Making 9: 142-149
274. Menzel, P. (1990). Strong Medicine. The Ethical Rationing of Health Care, Oxford University Press, New York et al.
275. Meyer, J. (1987). TwoMoment DecisionModels and Expected UtilityMaximization, American Economic Review 77: 421-430
276. MILLER, JR., R. AND FRECH, Iii, H. (2000). Is There a Link Between Pharmaceutical Consumption and Improved Health in OECD Countries?, PharmacoEconomics 18: 33- 45
277. MILLER, JR., R. AND FRECH, Iii, H. (2004a). Health Care Matters - Pharmaceuticals, Obesity, and the Quality of Life, AEI Press, Washington, DC.
278. MILLER, JR., R. AND FRECH, Iii, H. (2004b). Health Care Matters - Pharmaceuticals, Obesity, and the Quality of Life, AEI Press, Washington, DC.
279. Mirrlees, J. (1971). An Exploration in the Theory of Optimum Income Taxation, Review of Economic Studies 38: 175-208
280. Mitchell, R. AND Carson, R. (1989). Using Surveys to Value Public Goods: The Contingent Valuation Method, Resources for the Future, Washington, DC.
281. Miyamoto, J. (1999). Quality-Adjusted Life Years (QALY) Utility Models under Expected Utility and Rank Dependent Utility Assumptions, Journal of Mathematical Psychology 43: 201-237
282. Miyamoto, J. AND Eraker, S. (1988). A Multiplicative Model of the Utility of Survival Duration and Health Quality, Journal of Experimental Psychology: General 117: 3-20
283. MIYAMOTO, J., Wakker, P., Bleichrodt, H. AND Peters, H. (1998). The Zero-Condition: A Simplifying Assumption in QALY Measurement and Multiattribute Utility, Management Science 44: 839-849
284. Miyazaki, H. (1977). The Rat Race and Internal Labor Markets, Bell Journal of Economics 8: 394-418
285. Mooney, G. (2003). Economics, Medicine and Health Care, 3rd edition, Financial Times Prentice Hall, Harlow, England
286. Moore, S. (1979). Cost-Containment Through Risk Sharing by Primary Care Physicians, New England Journal of Medicine 300: 1359-1362
287. Mossin, J. (1968). Aspects of Rational Insurance Purchasing, Journal of Political Economy 76: 553-568
288. Mullahy, J. (1998). Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Econometrics, Journal of Health Economics 17: 247-282
289. Mullahy, J. AND Portney, P. (1990). Air Pollution, Cigarette Smoking, and the Production of Respiratory Health, Journal of Health Economics 9: 193-206
290. Murray, C. (1994). Quantifying the Burden of Disease: The Technical Basis for Disability-Adjusted Life Years, Bulletin of the World Health Organization 72: 429-445
291. Myles, G. (1995). Public Economics, Cambridge University Press, Cambridge
292. NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (2008). Guide to the Methods of Technology Appraisal, National Institute for Health and Clinical Excellence, London
293. Nelson, P. (1970). Information and Consumer Behavior, Journal of Political Economy 78(2
294. Newhouse, J. (1978). The Economics of Medical Care, Addison-Wesley, Cambridge, MA.
295. Newhouse, J. (1994). Frontier Estimation: How Useful a Tool for Health Economics?, Journal of Health Economics 13: 317-322
296. Newhouse, J. (1996). Reimbursing Health Plans and Health Providers: Efficiency in Production versus Selection, Journal of Economic Literature 34: 1236-1263
297. Newhouse, J. AND Friedlander, L. (1980). The Relationship Between Medical Resources and Measures of Health: Some Additional Evidence, Journal of Human Resources 15: 201-217
298. Newhouse, J., Manning, W., Keeling, E. AND Sloss, E. (1989). Adjusting Capitation Rates using Objective Health Measures and Prior Utilization, Health Care Financing Review 10: 41-54
299. Newhouse, J. P. (1992). Medical Care Costs: How Much Welfare Loss?, Journal of Economic Perspectives 6: 3-21
300. Newhouse, J. AND Phelps, C. (1976). New Estimates of Price and Income Elasticities of Medical Care Services, in R. ROSETT (ed.), The Role of Health Insurance in the Health Services Sector, National Bureau of Economic Reseach, New York, 261-312
301. Newhouse, J., Phelps, C. AND Marquis, M. (1980). On Having Your Cake and Eating it Too: Econometric Problems in Estimating the Demand for Health Services, Journal of Econometrics 13: 365-390
302. Nocera, S., Telser, H. AND Bonato, D. (2003). The Contingent-Valuation Method in Health Care - An Economic Evaluation of Alzheimer's Disease, Kluwer, Dordrecht
303. Nocera, S. AND Zweifel, P. (1998). The Demand for Health: An Empirical Test of the Grossman Model Using Panel Data, in P. ZWEIFEL (ed.), Health, the Medical Profession, and Regulation, Kluwer Academic Publishers, Boston, MA., 35-49
304. Nord, E. (1999). Cost-Value Analysis in Health Care: Making Sense Out of QALYs, Cambridge studies in philosophy and public policy, Cambridge University Press, Cambridge
305. Nordhaus, W. (1969). Invention, Growth and Welfare, MIT Press, Cambridge, MA.
306. Nuscheler, R. AND Knaus, T. (2005). Risk Selection in the German Public Health Insurance System, Health Economics 14: 1253-1271
307. Nyman, J. (1999a). The Economics ofMoral Hazard Revisited, Journal of Health Economics 18: 811-824
308. Nyman, J. (1999b). The Value of Health Insurance: The Access Motive, Journal of Health Economics 18: 141-152
309. Nyman, J. (2001). The Income Transfer Effect, the Access Value of Insurance and the Rand Health Insurance Experiment, Journal of Health Economics 20: 295-298
310. OECD (1987). Financing and Delivering Health Care. A Comparative Analysis of OECD Countries, OECD, Paris
311. OECD (2000). OECD Health Data, OECD, Paris
312. OECD (2001). OECD Health Data, OECD, Paris
313. OECD (2006). Employment and Labour Force Statistics: 1960-2005
314. OECD (2008). OECD Health Data, OECD, Paris
315. Olhansky, S., Rudberg, M., Cassel, C. AND Brody, J. (1991). Trading Off Longer Life for Worsening Health: The Expansion of Morbidity Hypothesis, Journal of Aging and Health 3: 194-216
316. Olson, M. (1965). The Logic of Collective Action, Harvard University Press, Cambridge, MA.
317. Ostro, B. (1983). The Effects of Air Pollution on Work Loss and Morbidity, Journal of Environmental Economics and Management 10: 371-382
318. Patel, V. AND Pauly, M. (2002). Guaranteed Renewability and the Problem of Risk Variation in Individual Health Insurance Markets, Health Affairs 21: W280-w289
319. http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.280v1
320. Pauly, M. (1974). Overinsurance and Public Provision of Insurance: The Role of Moral Hazard and Adverse Selection, Quarterly Journal of Economics 88: 44-62
321. Pauly, M. (1984). Is Cream-Skimming a Problem for the Competitive Medical Market?, Journal of Health Economics 3: 87-95
322. Pauly, M. (1988). Is Medical Care Different Old Questions, New Answers, Journal of Health Politics, Policy and Law 13: 227-237
323. Pauly, M. (1994). Editorial: A Re-Examination of the Meaning and Importance of Supplier-Induced Demand, Journal of Health Economics 13: 369-372
324. Pauly, M. (2000). Insurance Reimbursement, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 537-560
325. PAULY.M., Danzon, P., Feldstein, P. AND Hoff, J. (1992). Responsible National Health Insurance, Washington, DC, AEI Press
326. PAULY,M. AND Goodman, J. (1995). Tax Credits for Health Insurance andMedical Savings Accounts, Health Affairs 14 (1): 125-139
327. Pauly, M., KUNREUTHER, H. AND Hirth, R. (1995). Guaranteed Renewability in Insurance, Journal of Risk and Uncertainty 10: 143-156
328. Peckelman, D. AND Sen, S. (1979). Measurement and Estimation of Conjoint Utility Functions, Journal of Consumer Research 5: 263-271
329. PELTZMAN, S. (1973). An Evaluation of Consumer Protection Regulation: The 1962 Drug Amendment, Journal of Political Economy 81: 1049-1091
330. Persson, T. AND Tabellini, G. (2000). Political Economics, MIT Press, Cambridge, MA.
331. PHARMA INFORMATION (2001). Pharma-Markt Schweiz, Pharma Information, Basel
332. Phelps, C. (2003). Health Economics, 3rd edition, Harper Collins, New York
333. Phelps, C. AND Newhouse, J. (1972). Effects of Coinsurance: A Multivariate Analysis, Social Security Bulletin 35: 20-28
334. PHILIPSON, T. AND Becker, G. (1998). Old-Age Longevity and Mortality-Contingent Claims, Journal of Political Economy 106: 551-573
335. Phua, K. (1999). Comparative Health Care Financing Systems with Special Reference to East Asian Countries, Research in Healthcare Financial Management 5: 111-131
336. Pliskin, J., Shepard, D. AND Weinstein, M. (1980). Utility Functions for Life Years and Health Status, Operations Research 28: 206-224
337. POMMEREHNE,W., Schneider, F. AND Zweifel, P. (1982). Economic Theory of Choice and the Preference Reversal Phenomenon: A Reexamination, American Economic Review 72: 569-573
338. Pope, G. (1989). Hospital Nonprice Competition and Medicare Reimbursement Policy, Journal of Health Economics 8: 147-172
339. Ramsey, F. (1927). A Contribution to the Theory of Taxation, Economic Journal 37: 47-61
340. Ratcliffe, J. AND Buxton, M. (1999). Patient's Preferences Regarding the Process and Outcomes of Life-Saving Technology: An Application of Conjoint Analysis to Liver Transplantation, International Journal of Technology Assessment in Health Care 15: 340-51
341. Raviv, A. (1979). The Design of an Optimal Insurance Policy, American Economic Review 69: 84-96
342. Rawls, J. (1971). A Theory of Justice, Harvard University Press, Cambridge, MA.
343. Reekie, W. (1996). Medicine Prices and Innovations: An International Survey, Institute of Economic Affairs (IEA), London
344. REIS-Arndt, E. (1993). Neue pharmazeutische Wirkstoffe 1961-1990, Pharmazeutische Industrie 55: 14-21
345. Rice, T. (1983). The Impact of Changing Medicare Reimbursement Rates on Physician-Induced Demand, Medical Care 21: 803-815
346. Robinson, J. (2001). Theory and Practice in the Design of Physician Payment Incentives, Milbank Quarterly 79: 149-177
347. Roemer, J. (1996). Theories of Distributive Justice, Harvard University Press, Cambridge, MA.
348. Rogerson, W. (1985). The First-Order Approach to Principal-Agent Problems, Econometrica 53: 1357-1368
349. Roos, N., Roos, L. AND Henteleff, P. (1977). Elective Surgical Rates - Do High Rates Mean Lower Standards Tonsillectomy and Adenoidectomy in Manitoba, New England Journal of Medicine 297: 360-365
350. Rosa, J. AND Launois, R. (1990). Comparative Health Systems: France, Advances in Health Economics and Health Services Research 1 (Suppl.): 179-195
351. Rosen, S. (1988). The Value of Changes in Life Expectancy, Journal of Risk and Uncertainty 1: 285-304
352. Rosenzweig, M. AND Schultz, P. (1983). Estimating a Household Production Function: Heterogeneity, the Demand for Health Imputs, and Their Effects on BirthWeight, Journal of Political Economy 91: 723-746
353. Rothschild, M. AND Stiglitz, J. (1976). Equilibrium in Competitive Insurance Markets: An Essay in the Economics of Incomplete Information, Quarterly Journal of Economics 90: 629-649
354. Roussel, L. (1986). Recent Trends in the Structure of Households in Several Industrialized Countries, Population 41: 913-934
355. Rowley, C. AND Schneider, F. (eds.) (2003). The Encyclopedia of Public Choice, Kluwer, Dordrecht
356. Ryan, M. (1995). Economics and the Patient's Utility Function: An Application to Assisted Reproductive Techniques, PhD thesis, University of Aberdeen, Aberdeen
357. Ryan, M. AND Gerard, K. (2004). Using Choice Experiments to Value Health Care Programmes: Current Practice and Future Research Reflections, Applied Health Economics and Health Policy 2: 55-64
358. Ryan, M. AND Hughes, J. (1997). Using Conjoint Analysis to AssessWomen's Preferences for Miscarriage Management, Health Economics 6: 261-73
359. Ryan, M., Mcintosh, E. AND Shackley, P. (1998). Methodological Issues in the Application of Conjoint Analysis in Health Care, Health Economics 7: 373-78
360. SALA-I-Martin, X. (2005). The Median Voter Model, in G. LOPEZ-Casasnovas, B. RIVERA AND L. CURRAIS (eds.), Health and Economic Growth: Findings and Policy Implications, MIT Press, Cambridge, MA, 95-114
361. SALANÍe, B. (2003). Testing Contract Theory, CESifo Economic Studies 49(3): 461-477
362. Salkever, D. (2000). Regulation of Prices and Investment in Hospitals in the U.S., in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1489-1535
363. Sappington, D. AND Lewis, T. (1999). Using Subjective Risk Adjusting to Prevent Patient Dumping in the Health Care Industry, Journal of Economics and Management Strategy 8: 351-382
364. Scherer, F. (2000). The Pharmaceutical Industry, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1297-1338
365. SCHLANDER.M. (2007). Health Technology Assessments by the National Institute for Health and Clinical Excellence: A Qualitative Study, Innovation and Valuation in Health Care, Springer, New York
366. Schlesinger, H. (2000). The Theory of Insurance Demand, in G. DIONNE (ed.), Handbook of Insurance, Kluwer, Dordrecht, 131-152
367. Schlesinger, M., Blumenthal, D. AND Schlesinger, E. (1986). Profits under Pressure The Economic Performance of Investor-Owned and Nonprofit Health Maintenance Organizations, Medical Care 24: 615-627
368. Schokkaert, E. AND VAN DE Voorde, C. (2004). Risk Selection and the Specification of the Conventional Risk Adjustment Formula, Journal of Health Economics 23: 1237-1259
369. Schulenburg, J-M. GRAF V.D. (1989). Gesundheitswesen (Krankenversicherung) und demographische Evolution (The Health Care System (Health Insurance) and Demographic Evolution), in H. RECKTENWALD (ed.), Der Rückgang der Geburten-Folgen auf lángere Sicht, Verlag Wirtschaft und Finanzen, Düsseldorf, 279-297
370. Schut, F., Greenberg, W. AND VAN DE Ven, W. (1991). Antitrust Policy in the Dutch Health Care System and the Relevance of EEC Competition Policy and U.S. Antitrust Practice, Health Policy 17: 257-284
371. Schwabe, U. AND Paffrath, D. (2001). Arzneiverordnungs-Report 2001, Springer, Berlin
372. Scitovsky, A. AND Snider, N. (1972). Effect of Coinsurance on Use of Physician Services, Social Security Bulletin 35: 3-19
373. Seiford, L. AND Thrall, R. (1990). Recent Developments in DEA: The Mathematical Programming Approach to Frontier Analysis, Journal of Econometrics 46: 7-38
374. Selden, T. (1998). Risk Adjustment for Health Insurance: Theory and Implications, Journal of Risk and Uncertainty 17: 167-180
375. Selder, A. (2006). Medical Associations, Medical Education and Training on the Job, CESifo Economic Studies 52: 548-564
376. Shen, Y. AND Ellis, R. (2002). Cost-Minimizing Risk Adjustment, Journal of Health Economics 21: 515-530
377. Shepard, D. AND Zeckhauser, R. (1982). Life-Cycle Consumption and Willingness To Pay for Increased Survival, in M. JONES-LEE (ed.), Valuation of Life and Safety, North-Holland, Amsterdam, 95-155
378. Shepard, D. AND Zeckhauser, R. (1984). Survival Versus Consumption, Management Science 30: 423-439
379. Silver, M. (1972). An Econometric Analysis of Spatial Variations in Mortality Rates, in V. FUCHS (ed.), Essays in the Economics of Health, National Bureau of Economic Research, Washington, DC, 161-227
380. Sinn, H-W. (1983). Economic Decisions Under Uncertainty, North-Holland, Amsterdam
381. Sloan, F. (2000). Non-For-Profit Ownership and Hospital Behavior, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1141-1174
382. Smith, R. (2006). Trade in Health Services: Current Challenges and Future Prospects of Globalization, in A. JONES (ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, 164-175
383. Smith, V. (1968). Optimal Insurance Coverage, Journal of Political Economy 76: 68-77
384. Smith, V. AND Desvousges, W. (1987). An Empirical Analysis of the Economic Value of Risk Changes, Journal of Political Economy 95: 89-114
385. Spence, A. AND Zeckhauser, R. (1971). Insurance, Information, and Individual Action, American Economic Review, Papers and Proceedings 61: 380-387
386. Spence, M. (1978). Product Differentiation and Performance in Insurance Markets, Journal of Public Economics 10: 427-447
387. Stahl, I. (1990). Comparative Health Systems: Sweden, 1 (Suppl.): 197-210
388. Stearns, S. AND Norton, E. (2004). Time to Include Time to Death? The Future of Health Care Expenditure Predictions, Health Economics 13: 315-327
389. Steele, H. (1962). Monopoly and Competition in the Ethical Drug Market, Journal of Law and Economics 5: 131-163
390. Steinmann, L. AND Zweifel, P. (2003). On the (In)Efficiency of Swiss Hospitals, Applied Economics 35: 361-370
391. Stigler, G. AND Becker, G. (1977). De Gustibus Non Est Disputandum, American Economic Review 67: 76-90
392. Strombom, B., Buchmueller, T. AND Feldstein, P. (2002). Switching Costs, Price Sensitivity and Health Plan Choice, Journal of Health Economics 21: 89-116
393. Sydsæter, K., Strøm, A. AND Berck, P. (2005). Economists' Mathematical Manual, 4th edition, Springer, Heidelberg
394. Telser, H. (2002). Nutzenmessung im Gesundheitswesen - Die Methode der Discrete-Choice-Experimente, Verlag Dr. Kovac, Hamburg
395. Telser, H., Steinmann, L. AND Zweifel, P. (2007). The Impact of Ageing on Future Healthcare Expenditure, Forum for Health Economics and Policy 10(2): Article 1
396. http://www.bepress.com/fhep/10/2/1
397. Telser, H. AND Zweifel, P. (2002). Measuring Willingness-to-Pay for Risk Reduction: An Application of Conjoint Analysis, Health Economics 11: 129-139
398. Terporten, M. (1999). Wettbewerb in der Automobilindustrie: Eine industrieökonomische Untersuchung des deutschen PKW-Marktes unter besonderer Berücksichtigung der nationalen Hersteller (Competition in the Automobile Industry: The Industrial Economics of the German Car Market, with a Focus on National Manufacturers), PhD thesis, Universitát Duisburg
399. Thaler, R. AND Rosen, S. (1975). The Value of Saving a Life: Evidence from the Labor Market, in N. TERLECKYJI (ed.), Household Production and Consumption, Columbia University Press, New York, 265-302
400. Thornton, J. (2002). Estimating a Health Production Function for the US: Some New Evidence, Applied Economics 34: 59-62
401. Tikhomirov, V. (2001). Ĝateaux Variation, in M. HAZEWINKEL (ed.), Encyclopaedia of Mathematics, Kluwer, Dordrecht
402. Tobin, J. (1970). On Limiting the Domain of Inequality, Journal of Law and Economics 13: 263-277
403. Torrance, G. (1986). Measurement of Health State Utilities for Economic Appraisal, Journal of Health Economics 5: 1-30
404. Ubel, P. (2000). Pricing Life: Why It's Time for Health Care Rationing, MIT Press, Cambridge, MA.
405. U.S. CENSUS BUREAU (2004). Living Alone: 1940-2000, report, U.S. Census Bureau, Washington, DC.
406. Valletti, T. (2006). Differential Pricing, Parallel Trade, and the Incentive to Invest, Journal of International Economics 70: 314-324
407. VAN Barneveld, E., Lamers, L., VAN Vliet, R. AND VAN DE ven, W. (2001). Risk Sharing as a Supplement to Imperfect Capitation: A Tradeoff Between Selection and Efficiency, Journal of Health Economics 20: 147-168
408. VAN Barneveld, E., VAN Vliet, R. AND VAN DE ven, W. (1996). Mandatory High-Risk Pooling: An Approach to Reducing Incentives for Cream Skimming, Inquiry 33: 133-143
409. VAN Barneveld, E., VAN Vliet, R. AND VAN DE VEN, W. (1998). Mandatory Pooling as a Supplement to Risk-Adjusted Capitation Payments in a Competitive Health Insurance Market, Social Science and Medicine 47: 223-232
410. VAN DE Ven, W. AND ELLIS, R. (2000). Risk Adjustment in Competitive Health Plan Markets, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 755-845
411. VAN DE Ven, W. AND VAN VLIET, R. (1992). How Can We Prevent Cream Skimming in a Competitive Health Insurance Market?, in P. ZWEIFEL AND H. FRECH, III (eds.), Health Economics Worldwide, Kluwer, Dordrecht, 23-46
412. VAN DE ven, W., VAN VLIET, R., SCHUT, F. AND VAN BARNEVELD, E. (2000). Access to Coverage for High-Risks in a Competitive Individual Health Insurance Market: Via Premium Rate Restrictions or Risk-Adjusted Premium Subsidies?, Journal of Health Economics 19: 311-339
413. VAN vliet, R. (1992a). Predictability of Individual Health Care Expenditures, Journal of Risk and Insurance 59: 443-460
414. VAN Vliet, R. AND Lamers, L. (1998). The High Costs of Death: Should Health Plans Get Higher Payments when Members Die?, Medical Care 36: 1451-1460
415. Vane, J. (1964). A Plan for Evaluating Potential Drugs, in D. LAURENCE AND A. BACHARACH (eds.), Evaluation of Drug Activities: Pharmacometrics, Academic Press, London, 23-41
416. Varian, H. (1992). Microeconomic Analysis, 3rd EDITION, W.W. Norton, New York
417. VERBINDUNG DER SCHWEIZER á RZTINNEN UND áRZTE (2002). Mitgliederstatistik, Verbindung der Schweizer árztinnen und árzte (FMH). http://www.fmh.ch/ww/de/pub/homepage.htm
418. Verbrugge, L. (1984). Longer Life ButWorsening Health Trends in Health and Mortality of Middle-Aged and Older Persons, Milbank Memorial Fund Quarterly 62: 475-519
419. Vick, S. AND Scott, A. (1998). Agency in Health Care. Examining Patients Preferences for Attributes of the Doctor-Patient Relationship, Journal of Health Economics 17: 587-605
420. Virts, J. AND Weston, J. (1981). Expectations and the Allocation of Research and Development Resources, in R. HELMS (ed.), Drugs and Health, Enterprise Institute, Washington, DC, 21-45
421. Viscusi, W. (1993). The Value of Risks to Life and Health, Journal of Economic Literature 31: 1912-1946
422. Viscusi, W. AND Evans, W. (1990). Utility Functions that Depend on Health Status: Estimates and Economic Implications, American Economic Review 80: 353-374
423. Wagstaff, A. (1986a). The Demand for Health: A Simplified Grossman Model, Bulletin of Economic Research 38: 93-95
424. Wagstaff, A. (1986b). The Demand for Health: Some New Empirical Evidence, Journal of Health Economics 5: 195-233
425. Wagstaff, A. (1991). QALYs and the Equity-Efficiency Trade-Off, Journal of Health Economics 10: 21-41
426. Wagstaff, A. (1993). The Demand for Health: An Empirical Reformulation of the Grossman Model, Health Economics 2: 189-198
427. Walker, S. AND Parrish, J. (1988). Innovation and New Drug Development, in B. WALKER AND S. WALKER (eds.), Trends and Changes in Drug Research and Development, Kluwer, Dordrecht, 1-28
428. Walzer, M. (1983). Spheres of Justice, Basic Books, New York
429. Wardell, D., Diraddo, J. AND Trimble, A. (1980). Development of New Drugs Originated and Acquired by US-Owned Pharmaceutical Firms 1963-1976, Clinical Pharmacology and Therapy 28: 270-277
430. WARE, JR., J., Brook, R., Rogers, W., Keeler, E., Davies, A., Sherbourne, C., Goldberg, G., Camp, P. AND Newhouse, J. (1986). Comparison of Health Outcomes at a HealthMaintenance Organization with Those of Fee-For-Service Care, Lancet 326: 1017-1022
431. Weinstein, M. (1990). Principles of Cost-Effective Resource Allocation in Health Care Organizations, International Journal of Technology Assessment in Health Care 6: 93-103
432. Weinstein, M. (2006). Decision Rules for Incremental Cost-Effectiveness Analysis, in A. JONES (ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, 469-478
433. Weisbrod, B. (1968). Income Redistribution Effects and Benefit-Cost Analysis, in S. CHASE, Jr. (ed.), Problems in Public Expenditure Analysis, The Brookings Institution, Washington, DC, 177-209
434. Werblow, A., Felder, S. AND Zweifel, P. (2005). Population Ageing and Health Care Expenditure: A School of 'Red Herrings?, Health Economics 16: 1109-1126
435. Wiggins, S. (1987). The Cost of Developing a New Drug, Pharmaceutical Manufacturers' Association, Washington, DC.
436. Williams, A. AND Cookson, R. (2000). Equity in Health, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1B, Elsevier, Amsterdam, 1863- 1910
437. Williams, B. (1962). The Idea of Equality, in P. LASLETT AND W. G. RUNCIMAN (eds.), Philosophy, politics, and society, Series II, Blackwell, Oxford, 110-131
438. Williamson, O. (1981). The Modern Corporation: Origins, Evolution, Attributes, Journal of Economic Literature 19: 1537-1568
439. Wilson, C. (1977). A Model of Insurance Markets with Incomplete Information, Journal of Economic Theory 12: 167-207
440. Winter, R. (2000). Optimal Insurance under Moral Hazard, in G. DIONNE (ed.), Handbook of Insurance, Kluwer, Dordrecht, 155-184
441. WORLD BANK (1993). World Development Report 1993, Investing in Health, World Bank, Washington, DC.
442. WORLD BANK (2008). World Development Indicators, World Bank, Washington, DC.
443. WU, S. (1984). Social and Private Returns Derived from Pharmaceutical Innovations: Some Empirical Findings, in B. LINDGREN (ed.), Pharmaceutical Economics, Liber, Malmö, 217-254
444. Yip, W. (1998). Physician Responses to Medical Fee Reductions: Changes in Volume and Intensity of Supply of Coronary Artery Bypass Graft (CABG) Surgeries in the Medicare and Private Sectors, Journal of Health Economics 17: 675-700
445. Young, W. (1991). Patient Management Categories, in G. NEUBAUER AND G. SIEBEN (eds.), Alternative Entgeltverfahren in der Krankenhausversorgung, Beitráge zur Gesundheits ökonomie, Vol. 24, Bleicher, Gerlingen, 405-426
446. Zeckhauser, R. (1970). Medical Insurance: A Case Study of the Tradeoff Between Risk Spreading and Appropriate Incentives, Journal of Economic Theory 2: 10-26
447. Zuckermann, S., Hadley, J. AND Iezzoni, L. (1994). Measuring Hospital Efficiency with Frontier Cost Functions, Journal of Health Economics 13: 255-280
448. Zweifel, P. (1981). Supplier Induced Demand in a Model of Physician Behaviour, in J. VAN DER GAAG AND M. PERLMAN (eds.), Health, Economics and Health Economics, North Holland, Amsterdam, 245-267
449. Zweifel, P. (1984). Technological Change in Health Care: Why Are Opinions So Divided?, Managerial and Decision Economics 5: 177-182
450. Zweifel, P. (1985). The Effect of Aging on the Demand and Utilization of Medical Care, in C. TILQUIN (ed.), Systems Science in Health and Social Services for the Elderly and Disabled, Pergamon Press, Toronto, 313-318
451. Zweifel, P. (1990). Ageing: The Great Challenge to Health Care Reform, European Economic Review 34: 646-658
452. Zweifel, P. (1999). Suggestions for Health Policy in the 21st Century: An Economist's Point of View, in H. LöFFLER AND E. STREISSLER (eds.), Sozialpolitik und ökologieprobleme der Zukunft (Social Politics and Problems of Ecology in the Future), österreichische Akademie der Wissenschaften, Wien
453. Zweifel, P. (2000). Reconsidering the Role of Competition in Health Care Markets -
454. Switzerland, Journal of Health Politics, Policy and Law 25: 936-944
455. Zweifel, P. (2004). Multiple Payers in Health Care: A Framework for Assessment, in A. PREKER AND J. LANGENBRUNNER (eds.), Buying Health Services for the Poor, World Bank, New York, 319-38
456. Zweifel, P. AND BRAENDLE, A. (2008). What makes GPs Accept Changes?, mimeo, University of Zurich
457. Zweifel, P. AND Breuer, M. (2006). The Case for Risk-Based Premiums in Public Health Insurance, Health Economics, Policy and Law 1: 171-188
458. Zweifel, P. AND Crivelli, L. (1996). Price Regulation of Drugs: Lessons from Germany, Journal of Regulatory Economics 10: 257-274
459. Zweifel, P. AND Eichenberger, R. (1992). The Political Economy of Corporatism in Medicine: Self-Regulation or Cartel Management?, Journal of Regulatory Economics 4: 89-108
460. Zweifel, P. AND Eugster, P. (2008). Life-Cycle Effects of Social Security in an Open Economy: A Theoretical and Empirical Survey, Zeitschrift für die gesamte Versicherungswissenschaft - German Journal of Risk and Insurance 97: 61-77
461. Zweifel, P., Felder, S. AND Meier, M. (1999a). Ageing of Population and Health Care Expenditure: A Red Herring?, Health Economics 8: 485-496
462. Zweifel, P., Felder, S. AND Meier, M. (1999b). Ageing of Population and Health Expenditure: A Red Herring?, Health Economics 8: 485-496
463. Zweifel, P., Felder, S. AND Werblow, A. (2004a). Population Ageing and Health Care Expenditure: New Evidence on the 'Red Herring', Geneva Papers on Risk and Insurance: Issues and Practice 29: 652-66
464. Zweifel, P., Felder, S. AND Werblow, A. (2004b). Population Ageing and Health Care Expenditure: New Evidence on the Red Herring, The Geneva Papers on Risk and Insurance 29: 652-666
465. Zweifel, P. AND Ferrari, M. (1992). Is There a Sisyphus Syndrome in Health Care?, in P. ZWEIFEL AND H. FRECH, III (eds.), Health Economics Worldwide, Kluwer Academic Publishers, Dordrecht, Boston, London, 311-330
466. Zweifel, P. AND Grandchamp, C. (2002). Measuring the Effect of Cartelization in Medicine: An international Study, in D. SLOTTJE (ed.), Measuring Market Power, Nr. 255 in Contributions to Economic Analysis, Elsevier-North Holland, Amsterdam, 47-66
467. Zweifel, P., Krey, B. AND Tagli, M. (2007). Supply of Private Voluntary Health Insurance in Low-Income Countries, in A. Preker, R. SCHEFFLER AND M. BASSETT (eds.), Private Voluntary Health Insurance in Development: Friend or Foe?,World Bank, Washington, DC, 55-107
468. Zweifel, P. AND Lehmann, H. (2001). Soziale Absicherung im Portfolio persönlicher Aktiva:Wie kann die Soziale Sicherung Teufelskreise verhindern (Hedging the Portfolio of Personal Assets: How Can Social Insurance Avoid Vicious Cycles), in E. THEURL (ed.), Der Sozialstaat an der Jahrtausendwende, Physica Verlag, Heidelberg, 53-75
469. Zweifel, P., Lyttkens, C. AND SöDERSTRöm, L. (eds.) (1998). Regulation of Health: Case Studies of Sweden and Switzerland, Nr. 7 in Development in Health Economics and Public Policy, Kluwer Academic Publishers, Boston
470. Zweifel, P. AND Manning, W. (2000). Moral Hazard and Consumer Incentives in Health Care, in A. CULYER AND J. NEWHOUSE (eds.), Handbook of Health Economics, Vol. 1A, Elsevier, Amsterdam, 409-459
471. Zweifel, P. AND Pedroni, G. (1985). Innovation und Imitation - Eine wirtschaftspolitische Gratwanderung (Innovation and Imitation - A Knife-Edge Issue), Studien zur Gesundheits ökonomie 7, Pharma Information, Basel
472. Zweifel, P., Steinmann, L. AND Eugster, P. (2005). The Sisyphus Syndrome in Health Revisited, International Journal of Health Care Finance and Economics 5: 127-145
473. Zweifel, P., Telser, H. AND Vaterlaus, S. (2006). Consumer Resistance Against Regulation: The Case of Health Care, Journal of Regulatory Economics 29: 319-332
474. Zweifel, P. AND Waser, O. (1992). Bonus Options in Health Insurance, Kluwer, Dordrecht
475. Zweifel, P. AND Zaech, R. (2003). Vertical Restraints: The Case of Multinationals, The Antitrust Bulletin 48: 271-298